Drug makers

Renata to issue Tk325cr preference shares
Stocks

Renata to issue Tk325cr preference shares

The proposed preference shares will be non-cumulative, non-participative, redeemable or fully convertible, said the drug producer in a filing with DSE

Renata launches new drug in UK market
Stocks

Renata launches new drug in UK market

The price of Chinese raw materials Indian drug makers need to produce ivermectin has soared, a trade group says. Photo: Shutterstock via South China Morning Post
Coronavirus chronicle

India’s Covid-19 drug makers see Chinese raw material prices soar

The urgent need for effective Covid-19 treatments and vaccines is causing a shift in drugmakers’ priorities. Photographer: Andrey Rudakov/Bloomberg
Panorama

Pharma rivals are fighting Covid together. Why stop there?